Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03105336 |
|---|---|
| Brief Title: | A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5) |
| First Submitted : | April 3, 2017 |
| First Submitted that Met QC Criteria : | April 3, 2017 |
| First Posted : | April 7, 2017 |
| Last Update Submitted that Met QC Criteria : | February 23, 2024 |
| Last Update Posted : | February 26, 2024 |